Among them, EZH2 was selected as the most potential ccRCC CSC marker, which was significantly higher expressed in the sphere cell lines than in the adherent cell lines on the mRNA level as well as on the protein level, with the ability to be an OS-related prognostic factor. Here, EZH2 is linked to nonpapillary renal cell carcinoma.